Purchases and Sales Made in Q4 2022 in Virax Biolabs Group LTD (VRAX)
This table provides information about the institutional ownership of Virax Biolabs Group LTD (VRAX) during Q4 2022. The information is specifically focused on institutions that hold shares of Virax Biolabs Group Ltd.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Mar 29, 2024
Q4 2022
|
Kapitalo Investimentos Ltda
Sao Paulo, D5 |
BUY
|
- |
118KNew |
$67K - $3.36M
|
118K
$231K
|
|
|
Feb 14, 2023
Q4 2022
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
103KNew |
$58.5K - $2.93M
|
103K
$202K
|
|
|
Feb 15, 2023
Q4 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
48.5KNew |
$27.6K - $1.39M
|
48.5K
$95.5K
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
15.4KNew |
$8.78K - $440K
|
15.4K
$30.3K
|
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
11.4KNew |
$6.5K - $326K
|
11.4K
$22.5K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
853New |
$486 - $24.4K
|
853
$1.68K
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-6.01K- 49.29% |
$3.43K - $172K
|
6.19K
$12.2K
|